Austco Research Development vs Interest Expense Analysis

AHC Stock

0.25 0.01 4.17%

Austco Healthcare financial indicator trend analysis is way more than just evaluating Austco Healthcare prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Austco Healthcare is a good investment. Please check the relationship between Austco Healthcare Research Development and its Interest Expense accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Austco Healthcare. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Research Development vs Interest Expense

Research Development vs Interest Expense Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Austco Healthcare Research Development account and Interest Expense. At this time, the significance of the direction appears to have almost no relationship.

The correlation between Austco Healthcare's Research Development and Interest Expense is 0.19. Overlapping area represents the amount of variation of Research Development that can explain the historical movement of Interest Expense in the same time period over historical financial statements of Austco Healthcare, assuming nothing else is changed. The correlation between historical values of Austco Healthcare's Research Development and Interest Expense is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Research Development of Austco Healthcare are associated (or correlated) with its Interest Expense. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Interest Expense has no effect on the direction of Research Development i.e., Austco Healthcare's Research Development and Interest Expense go up and down completely randomly.

Correlation Coefficient

0.19

Relationship Direction	Positive
Relationship Strength	Insignificant

View All Relationships

Research Development

Interest Expense

The cost incurred by an entity for borrowed funds, including loans, bonds, or lines of credit.

Most indicators from Austco Healthcare's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Austco Healthcare current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Austco Healthcare. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Selling General Administrative is likely to drop to about 1.4 M in 2024. Tax Provision is likely to gain to about (378.8 K) in 2024

	2021	2022	2023	2024 (projected)
Interest Expense	52K	68K	149K	91.5K
Depreciation And Amortization	1.4M	1.7M	2.3M	2.4M

Interest Expense Depreciation And Amortization

Austco Healthcare fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Common Stock	Good Will	Short Term Investments	Other Stockholder Equity	Non Currrent Assets Other
Total Assets		0.22	0.43	0.7	0.99	0.95	-0.91	0.42	0.59	0.93	0.95	0.93	0.72	0.46	0.93	0.5	0.46	0.97	0.96	-0.1	0.53	0.55	0.16	0.16	0.31	0.82
Short Long Term Debt Total	0.22		-0.21	0.2	0.19	0.31	-0.08	-0.1	0.2	0.21	0.28	0.21	0.07	0.0	0.31	0.05	-0.03	0.26	0.14	0.85	0.07	0.3	-0.63	0.41	0.12	0.38
Other Current Liab	0.43	-0.21		0.52	0.39	0.41	-0.52	-0.21	0.26	0.47	0.3	0.47	0.39	0.6	0.4	0.47	0.39	0.48	0.49	-0.44	-0.25	0.6	0.64	0.39	-0.35	0.32
Total Current Liabilities	0.7	0.2	0.52		0.66	0.52	-0.6	-0.02	0.95	0.59	0.53	0.59	0.88	0.76	0.52	0.91	0.6	0.76	0.79	-0.11	0.17	0.81	0.38	0.62	0.1	0.45
Total Stockholder Equity	0.99	0.19	0.39	0.66		0.95	-0.93	0.48	0.54	0.94	0.95	0.94	0.71	0.45	0.92	0.45	0.49	0.94	0.95	-0.12	0.6	0.51	0.16	0.11	0.35	0.79
Property Plant And Equipment Net	0.95	0.31	0.41	0.52	0.95		-0.88	0.49	0.38	0.92	0.97	0.92	0.55	0.29	0.98	0.28	0.33	0.91	0.85	-0.03	0.53	0.43	0.04	0.05	0.27	0.89
Net Debt	-0.91	-0.08	-0.52	-0.6	-0.93	-0.88		-0.35	-0.42	-0.99	-0.82	-0.99	-0.61	-0.59	-0.83	-0.41	-0.65	-0.84	-0.9	0.28	-0.49	-0.59	-0.4	-0.18	-0.17	-0.61
Retained Earnings	0.42	-0.1	-0.21	-0.02	0.48	0.49	-0.35		0.01	0.34	0.6	0.34	0.18	-0.35	0.48	-0.19	-0.05	0.28	0.24	-0.19	0.86	-0.42	-0.14	-0.68	0.52	0.5
Accounts Payable	0.59	0.2	0.26	0.95	0.54	0.38	-0.42	0.01		0.42	0.42	0.42	0.83	0.63	0.37	0.91	0.51	0.66	0.69	-0.02	0.2	0.67	0.25	0.54	0.21	0.35
Cash	0.93	0.21	0.47	0.59	0.94	0.92	-0.99	0.34	0.42		0.87	1.0	0.58	0.54	0.88	0.38	0.59	0.87	0.91	-0.15	0.48	0.59	0.27	0.18	0.19	0.68
Non Current Assets Total	0.95	0.28	0.3	0.53	0.95	0.97	-0.82	0.6	0.42	0.87		0.87	0.57	0.19	0.98	0.26	0.23	0.91	0.82	-0.03	0.64	0.33	-0.04	-0.05	0.39	0.92
Cash And Short Term Investments	0.93	0.21	0.47	0.59	0.94	0.92	-0.99	0.34	0.42	1.0	0.87		0.58	0.54	0.88	0.38	0.59	0.87	0.91	-0.15	0.48	0.59	0.27	0.18	0.19	0.68
Net Receivables	0.72	0.07	0.39	0.88	0.71	0.55	-0.61	0.18	0.83	0.58	0.57	0.58		0.7	0.53	0.71	0.59	0.71	0.78	-0.19	0.42	0.7	0.3	0.48	0.3	0.43
Common Stock Shares Outstanding	0.46	0.0	0.6	0.76	0.45	0.29	-0.59	-0.35	0.63	0.54	0.19	0.54	0.7		0.22	0.75	0.85	0.46	0.65	-0.26	-0.07	0.92	0.62	0.76	-0.17	0.0
Non Current Liabilities Total	0.93	0.31	0.4	0.52	0.92	0.98	-0.83	0.48	0.37	0.88	0.98	0.88	0.53	0.22		0.25	0.21	0.92	0.82	-0.03	0.5	0.39	0.01	0.02	0.27	0.94
Inventory	0.5	0.05	0.47	0.91	0.45	0.28	-0.41	-0.19	0.91	0.38	0.26	0.38	0.71	0.75	0.25		0.59	0.58	0.66	-0.1	-0.07	0.73	0.47	0.6	-0.03	0.21
Other Current Assets	0.46	-0.03	0.39	0.6	0.49	0.33	-0.65	-0.05	0.51	0.59	0.23	0.59	0.59	0.85	0.21	0.59		0.38	0.61	-0.26	0.15	0.7	0.54	0.52	-0.02	0.01
Total Liab	0.97	0.26	0.48	0.76	0.94	0.91	-0.84	0.28	0.66	0.87	0.91	0.87	0.71	0.46	0.92	0.58	0.38		0.95	-0.05	0.38	0.6	0.16	0.24	0.22	0.84
Total Current Assets	0.96	0.14	0.49	0.79	0.95	0.85	-0.9	0.24	0.69	0.91	0.82	0.91	0.78	0.65	0.82	0.66	0.61	0.95		-0.14	0.39	0.69	0.31	0.32	0.21	0.67
Short Term Debt	-0.1	0.85	-0.44	-0.11	-0.12	-0.03	0.28	-0.19	-0.02	-0.15	-0.03	-0.15	-0.19	-0.26	-0.03	-0.1	-0.26	-0.05	-0.14		-0.11	0.0	-0.76	0.22	0.09	0.12
Intangible Assets	0.53	0.07	-0.25	0.17	0.6	0.53	-0.49	0.86	0.2	0.48	0.64	0.48	0.42	-0.07	0.5	-0.07	0.15	0.38	0.39	-0.11		-0.12	-0.16	-0.38	0.71	0.41
Common Stock	0.55	0.3	0.6	0.81	0.51	0.43	-0.59	-0.42	0.67	0.59	0.33	0.59	0.7	0.92	0.39	0.73	0.7	0.6	0.69	0.0	-0.12		0.38	0.89	-0.11	0.23
Good Will	0.16	-0.63	0.64	0.38	0.16	0.04	-0.4	-0.14	0.25	0.27	-0.04	0.27	0.3	0.62	0.01	0.47	0.54	0.16	0.31	-0.76	-0.16	0.38		0.15	-0.41	-0.19
Short Term Investments	0.16	0.41	0.39	0.62	0.11	0.05	-0.18	-0.68	0.54	0.18	-0.05	0.18	0.48	0.76	0.02	0.6	0.52	0.24	0.32	0.22	-0.38	0.89	0.15		-0.17	-0.05
Other Stockholder Equity	0.31	0.12	-0.35	0.1	0.35	0.27	-0.17	0.52	0.21	0.19	0.39	0.19	0.3	-0.17	0.27	-0.03	-0.02	0.22	0.21	0.09	0.71	-0.11	-0.41	-0.17		0.26
Non Currrent Assets Other	0.82	0.38	0.32	0.45	0.79	0.89	-0.61	0.5	0.35	0.68	0.92	0.68	0.43	0.0	0.94	0.21	0.01	0.84	0.67	0.12	0.41	0.23	-0.19	-0.05	0.26

Click cells to compare fundamentals

Austco Healthcare Account Relationship Matchups

Austco Healthcare fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	23.1M	27.2M	34.0M	37.9M	68.7M	72.1M
Short Long Term Debt Total	892K	1.2M	979K	524K	1.8M	1.3M
Other Current Liab	3.3M	1.4M	1.5M	1.6M	3.6M	2.3M
Total Current Liabilities	6.3M	7.2M	10.5M	12.6M	17.1M	9.1M
Total Stockholder Equity	16.3M	19.3M	23.1M	25.0M	44.4M	46.6M
Property Plant And Equipment Net	1.3M	1.2M	1.1M	848K	3.5M	3.7M
Net Debt	(5.6M)	(6.6M)	(6.6M)	(4.1M)	(11.8M)	(11.2M)
Retained Earnings	(24.7M)	(21.3M)	(18.9M)	(17.9M)	(10.6M)	(11.2M)
Accounts Payable	2.5M	3.6M	6.7M	8.3M	9.3M	4.8M
Cash	6.4M	7.8M	7.6M	4.7M	13.6M	14.2M
Non Current Assets Total	5.0M	5.5M	6.7M	8.1M	28.1M	29.5M
Cash And Short Term Investments	6.4M	7.8M	7.6M	4.7M	13.6M	14.2M
Net Receivables	5.1M	6.7M	8.2M	12.8M	14.5M	8.0M
Common Stock Shares Outstanding	262.2M	285.0M	285.1M	291.5M	309.0M	199.3M
Liabilities And Stockholders Equity	23.1M	27.2M	34.0M	37.9M	68.7M	72.1M
Non Current Liabilities Total	580K	643K	456K	215K	7.3M	7.6M
Inventory	5.2M	5.1M	9.2M	10.8M	10.7M	6.2M
Other Current Assets	1.4M	2.1M	2.3M	1.5M	1.8M	937.4K
Total Liab	6.8M	7.9M	10.9M	12.9M	24.3M	25.5M
Total Current Assets	18.1M	21.7M	27.3M	29.8M	40.6M	42.6M
Short Term Debt	301K	538K	559K	401K	573K	976K
Intangible Assets	2.9M	3.6M	4.7M	5.5M	6.3M	5.3M
Other Stockholder Equity	(430K)	(863K)	273K	1.0	0.9	0.95
Non Currrent Assets Other	(1.3M)	(1.2M)	(1.1M)	(848K)	10.2M	10.7M
Accumulated Other Comprehensive Income	(430K)	(863K)	273K	668.0K	539K	566.0K
Other Assets	3.7M	4.4M	5.6M	7.2M	1.0	0.95
Long Term Debt Total	565K	615K	420K	123K	141.5K	243.0K
Property Plant Equipment	1.3M	1.2M	1.1M	848K	975.2K	914.5K
Other Liab	15K	28K	36K	52K	59.8K	30.0K
Net Tangible Assets	16.3M	19.3M	23.1M	25.0M	28.7M	17.6M
Net Invested Capital	16.3M	19.3M	23.1M	25.0M	28.8M	18.0M
Cash And Equivalents	6.4M	7.8M	7.6M	4.7M	5.4M	5.1M
Net Working Capital	11.9M	14.4M	16.9M	17.2M	19.7M	13.2M
Deferred Long Term Liab	2.9M	3.6M	4.7M	5.5M	6.3M	3.5M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Austco Stock Analysis

When running Austco Healthcare's price analysis, check to measure Austco Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Austco Healthcare is operating at the current time. Most of Austco Healthcare's value examination focuses on studying past and present price action to predict the probability of Austco Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Austco Healthcare's price. Additionally, you may evaluate how the addition of Austco Healthcare to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC